deucravacitinib
noun1
- A medication belonging to the class of Janus kinase inhibitors, used for the treatment of moderate-to-severe plaque psoriasis.
- Deucravacitinib (BMS-986165) has shown efficacy in a psoriasis trial (65) and significantly greater American College of Rheumatology 20% improvement rates compared to placebo in patients with PsA. — 2021